Taiwanese company United Biomedical Inc. (UBI) Asia on Wednesday applied for emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine candidate, after releasing the interim results of its Phase 2 clinical trials last weekend, according to its subsidiary.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Mandarin Airlines A321neo makes domestic debut on domestic route
09/13/2026 07:31 PM - Sports
Dwight Howard headlines New Taipei Kings charity event
09/13/2026 06:07 PM - Society
Western Taiwan sees hot weather Sunday
09/13/2026 05:38 PM - Culture
French film critic helped bring Taiwan New Cinema to world: Minister
09/13/2026 05:17 PM - Sports